resveratrol has been researched along with Lymphoma, Large B-Cell, Diffuse in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, M; Ahmed, SO; Al-Kuraya, KS; Bu, R; Hussain, AR; Khan, OS; Uddin, S | 1 |
| Blair, D; Chiles, TC; Dufort, FJ; Faber, AC; Roberts, MF; Wagner, D | 1 |
2 other study(ies) available for resveratrol and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Resveratrol suppresses constitutive activation of AKT via generation of ROS and induces apoptosis in diffuse large B cell lymphoma cell lines.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Cytochromes c; Humans; Immunoblotting; Lymphoma, Large B-Cell, Diffuse; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes | 2011 |
Inhibition of phosphatidylinositol 3-kinase-mediated glucose metabolism coincides with resveratrol-induced cell cycle arrest in human diffuse large B-cell lymphomas.
Topics: Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Line, Tumor; Chromones; Enzyme Inhibitors; Glucose; Glycolysis; Humans; Lymphoma, Large B-Cell, Diffuse; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Resveratrol; Stilbenes | 2006 |